Dr Sewanti Limaye

Attached To

Kokilaben Dhirubhai Ambani Hospital

&

Medical Research Centre

Mumbai

  • Get Expert Second Opinion
  • Get In Person Priority Consultation
  • Get treated through Medical Travel

Consultant Medical Oncologist

Diplomate American Board, Fellowship, MS, MD, MBBS

Expertise

  • All solid tumours including Head & neck, Lung, Breast, Sarcoma, Gastrointestinal, Genitourinary and Gynaecological cancers
  • Cancer Genomics
  • Chemotherapy, Targeted Therapy and Immunotherapy

Training, Certification & Fellowship

  • Fellowship in Haematology & Medical Oncology – Albert Einstein University, North Shore, Long Island Jewish Medical Centre, New York, USA
  • Masters of Science (MS) – Patient Oriented Research (Cancer Genomics & Biostatistics) – Columbia University, USA
  • Diplomate American Board – Internal Medicine, Haematology and Medical Oncology
  • MD, Residency in Internal Medicine – New York University, USA
  • MBBS – India

Professional Profile

  • Dr Limaye is board certified in Internal Medicine, Haematology and Medical Oncology and has been a practising Medical Oncologist for over 10 years.
  • She has worked at the prestigious Columbia University Medical Centre / New York Presbyterian Hospital, USA as an Attending in Medical Oncology and Assistant Professor of Medicine.
  • She has worked as an Attending in Medical Oncology at the Dana Farber Cancer Institute / Brigham & Women’s Hospital and at the Phase I – Early Drug Development Centre – Harvard Medical School, Boston USA.
  • Along with chemotherapy, she has specific expertise in Cancer Genomics, Targeted Therapy and cutting edge treatment with Immunotherapy.
  • She has been involved in research with leaders at MSKCC, Dana Farber Cancer Institute, Colombia University Medical Centre and National Cancer Institute, USA.
  • She has led several national and international trails and has been a part of Data Safety Monitoring Boards.
  • She has been awarded with the John – Flynn Young investigator award for Excellence in Clinical Research.